Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow
Open Access
- 15 November 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (10) , 3780-3792
- https://doi.org/10.1182/blood.v92.10.3780
Abstract
Expression of the 210-kD bcr/abl fusion oncoprotein can cause a chronic myelogenous leukemia (CML)-like disease in mice receiving bone marrow cells tKeywords
This publication has 46 references indexed in Scilit:
- Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.The Journal of Experimental Medicine, 1996
- The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865]The Journal of cell biology, 1994
- Improved Methods of Retroviral Vector Transduction and Production for Gene TherapyHuman Gene Therapy, 1994
- Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.The Journal of Experimental Medicine, 1994
- Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformationNature, 1993
- Integration of Molecular and Biological Abnormalities in Quest for Selective Treatment of Chronic Myelogenous Leukemia (CML)Leukemia & Lymphoma, 1993
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22Cell, 1984